Large Scale Biology is shutting down its fee-for-service proteomics contract business and is “reviewing and evaluating its business, prospects, and programs” in regards to the rest of its Germantown, Md.-based proteomics business, the company said in a series of reports over the past week. The news was punctuated by a sharp 44 percent drop in the company’s stock price on Friday. (The stock has since recovered, but has not reached its Nov. 13 levels.)
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.